CLYYF OTC
Celyad Oncology S.A.
1W: +0.0%
1M: +0.0%
3M: +12.0%
YTD: +86.7%
1Y: -31.7%
3Y: -99.4%
$0.28
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$10M
-39.0% ▼
5Y CAGR: -35.6%
Total Liabilities
$26M
+161.1% ▲
5Y CAGR: -10.0%
Shareholders Equity
-$16M
-355.7% ▼
Cash & Investments
$4M
-40.0% ▼
5Y CAGR: -36.1%
Total Debt
$18M
+1557.5% ▲
5Y CAGR: +32.1%
Net Debt
$13M
+324.3% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $17M | $30M | $12M | $7M | $4M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash & ST Investments | $17M | $30M | $12M | $7M | $4M |
| Net Receivables | $907K | $2M | $1M | $380K | $908K |
| Inventory | $0 | $0 | $0 | $1M | $417K |
| Other Current Assets | $1K | $0 | $245K | $1M | $0 |
| Total Current Assets | $20M | $34M | $15M | $11M | $7M |
| Property, Plant & Equip. | $4M | $3M | $309K | $2M | $1M |
| Goodwill & Intangibles | $36M | $36M | $864K | $390K | $405K |
| Long-Term Investments | $6M | $2M | $0 | $3M | $1M |
| Other Non-Current Assets | $6M | $6M | $4M | $137K | $95K |
| Total Non-Current Assets | $46M | $46M | $5M | $5M | $3M |
| Total Assets | $66M | $80M | $20M | $16M | $10M |
| — Liabilities — | |||||
| Accounts Payable | $5M | $7M | $5M | $1M | $1M |
| Short-Term Debt | $37K | $902K | $137K | $0 | $142K |
| Deferred Revenue | $2M | $1M | $1M | $0 | $785K |
| Other Current Liabilities | $2M | $2M | $3M | $1M | $175K |
| Total Current Liabilities | $12M | $14M | $10M | $3M | $3M |
| Long-Term Debt | -$16M | -$15M | $0 | $0 | $17M |
| Other Non-Current Liab. | $17M | $15M | $271K | $2M | $2M |
| Total Non-Current Liabilities | $23M | $22M | $5M | $24M | $23M |
| Total Liabilities | $35M | $36M | $15M | $10M | $26M |
| — Equity — | |||||
| Common Stock | $49M | $79M | $79M | $33M | $8M |
| Retained Earnings | -$92M | -$309M | -$350M | -$358M | -$364M |
| Accumulated OCI | $31M | $268M | $269M | $332M | $340M |
| Total Stockholders Equity | $31M | $44M | $4M | $6M | -$16M |
| Total Liabilities & Equity | $66M | $80M | $20M | $16M | $10M |
| — Key Metrics — | |||||
| Total Debt | $4M | $3M | $255K | $1M | $18M |
| Net Debt | -$14M | -$27M | -$12M | -$6M | $13M |
| Total Investments | $6M | $2M | $0 | $3M | $1M |